Abstract

We constructed an optimal machine learning (ML) method for predicting intravenous immunoglobulin (IVIG) resistance in children with Kawasaki disease (KD) using commonly available clinical and laboratory variables. We retrospectively collected 98 clinical records of hospitalized children with KD (2–109 months of age). We found that 20 (20%) children were resistant to initial IVIG therapy. We trained three ML techniques, including logistic regression, linear support vector machine, and eXtreme gradient boosting with 10 variables against IVIG resistance. Moreover, we estimated the predictive performance based on nested 5-fold cross-validation (CV). We also selected variables using the recursive feature elimination method and performed the nested 5-fold CV with selected variables in a similar manner. We compared ML models with the existing system regardless of their predictive performance. Results of the area under the receiver operator characteristic curve were in the range of 0.58–0.60 in the all-variable model and 0.60–0.75 in the select model. The specificities were more than 0.90 and higher than those in existing scoring systems, but the sensitivities were lower. Three ML models based on demographics and routine laboratory variables did not provide reliable performance. This is possibly the first study that has attempted to establish a better predictive model. Additional biomarkers are probably needed to generate an effective prediction model.

Highlights

  • In developed countries, Kawasaki disease (KD) is the major cause of acquired heart disease in children [1]

  • The American Heart Association has reported that patients who were predicted to be at a high risk for development of coronary artery abnormality (CAA) may benefit from primary adjunctive therapy such as intravenous immunoglobulin (IVIG) and corticosteroids [2]

  • We evaluated the predictive performance of the three supervised machine learning (ML) classifiers and existing scoring systems

Read more

Summary

Introduction

Kawasaki disease (KD) is the major cause of acquired heart disease in children [1]. The effectiveness of high-dose intravenous immunoglobulin (IVIG) therapy has been established as an initial KD treatment [2]. Approximately 10–20% children with KD are Kawasaki Disease and Machine Learning refractory to this treatment and develop persistent or recurrent fever after initial IVIG therapy [3, 4]. IVIG resistance is a risk factor for the occurrence of CAA [5]. The American Heart Association has reported that patients who were predicted to be at a high risk for development of CAA may benefit from primary adjunctive therapy such as IVIG and corticosteroids [2]. Developing a reliable tool for predicting IVIG resistance is important to reduce the occurrence of CAA

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call